The Therapeutic Goods
Administration has established the
third version of evidence guidelines
which were first published in Oct
2001, reformatted in April 2011
and now updated in this latest
version.
The Evidence guidelines:
Guidelines on the evidence required
to support indications for listed
complementary medicines specifies
the type of evidence required
to support indications made
for listed medicines (excluding
sunscreens and disinfectants) and
help sponsors understand their
regulatory obligations in relation to
holding that evidence.
The TGA posting of this update
includes listed complementary
medicine compliance reviews.
For see the guidelines update, go
to www.tga.gov.au.The above article was sent to subscribers in Pharmacy Daily's issue from 26 Mar 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 26 Mar 14
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.